Molina Healthcare (NYSE:MOH) had its target price lowered by Morgan Stanley from $94.00 to $91.00 in a report issued on Wednesday. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 24.23% from the stock’s current price.
MOH has been the subject of several other research reports. Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Molina Healthcare in a research note on Wednesday. Zacks Investment Research raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. ValuEngine raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Leerink Swann increased their price objective on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, January 9th. Finally, Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $72.50.
Shares of Molina Healthcare (MOH) traded down $2.21 during trading on Wednesday, hitting $73.25. 1,376,860 shares of the stock were exchanged, compared to its average volume of 1,464,112. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $93.98. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market cap of $4,250.00, a P/E ratio of -9.07, a PEG ratio of 0.91 and a beta of 1.10.
Several hedge funds have recently added to or reduced their stakes in MOH. Iridian Asset Management LLC CT bought a new position in shares of Molina Healthcare during the fourth quarter valued at $128,179,000. Renaissance Technologies LLC increased its position in shares of Molina Healthcare by 53.5% during the fourth quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after buying an additional 751,800 shares during the period. Jana Partners LLC increased its position in shares of Molina Healthcare by 52.5% during the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after buying an additional 731,992 shares during the period. Tavio Capital LLC increased its position in shares of Molina Healthcare by 418.0% during the third quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock worth $36,937,000 after buying an additional 433,485 shares during the period. Finally, Victory Capital Management Inc. increased its position in shares of Molina Healthcare by 36.0% during the fourth quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock worth $121,953,000 after buying an additional 420,756 shares during the period. 96.22% of the stock is owned by hedge funds and other institutional investors.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.